Rockwell Medical
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
4213.122.38
Price/Sales ratio
0.960.770.66
Earnings per Share (EPS)
$0.02$0.08$0.44

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-19.76-35.31-16.76-11.41-3.71-4.78-2.39-1.09-0.48-5.22-1.26-3.71
Price/Sales ratio
7.789.196.225.161.882.421.220.620.130.520.322.42
Price/Book Value ratio
6.138.176.268.984.377.312.2315.160.702.071.677.31
Price/Cash Flow ratio
99.02-31.35-26.65-14.00-5.84-5.45-2.57-1.14-0.57-4.68-2.15-5.84
Price/Free Cash Flow ratio
117.99-29.85-25.91-12.97-5.57-5.19-2.48-1.12-0.56-4.54-2.13-5.57
Price/Earnings Growth ratio
0.300.79-0.48-0.37-0.190.290.130.090.000.06-0.01-0.19
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
15.76%16.14%12.67%6.46%-2.49%4.63%4.38%-3.90%5.59%10.41%5.59%-2.49%
Operating Profit Margin
-32.40%-27.28%-37.92%-45.24%-51.17%-55.61%-45.69%-48.98%-23.04%-7.97%-23.04%-51.17%
Pretax Profit Margin
-39.35%-26.05%-36.40%-45.23%-50.68%-55.67%-49.66%-52.75%-25.65%-10.09%-25.65%-50.68%
Net Profit Margin
-39.35%-26.05%-37.16%-45.23%-50.68%-50.69%-51.34%-56.56%-28.26%-10.09%-25.65%-50.68%
Effective Tax Rate
-1.81%N/A-2.08%0.00%-0.97%8.93%-3.37%-7.22%-10.16%N/AN/A-0.97%
Return on Assets
-21.76%-16.42%-23.81%-44.09%-61.12%-70.12%-41.07%-72.12%-44.12%-16.17%-40.05%-61.12%
Return On Equity
-31.04%-23.13%-37.39%-78.75%-117.77%-152.94%-93.45%-1382.01%-145.88%-39.63%-163.92%-152.94%
Return on Capital Employed
-19.90%-18.94%-27.68%-52.22%-82.43%-106.73%-43.75%-109.88%-57.97%-18.76%-57.98%-82.43%
Liquidity Ratios
Current Ratio
9.6510.457.735.343.542.985.43N/AN/AN/A1.212.98
Quick Ratio
9.259.486.544.503.242.685.121.481.661.372.212.68
Cash ratio
6.713.851.690.911.720.953.800.631.210.531.211.21
Days of Sales Outstanding
30.1233.2743.7940.4842.3225.02K24.4734.8431.3747.5831.3725.02K
Days of Inventory outstanding
31.3461.9095.2352.0022.6822.7624.0123.1130.8728.6030.8722.68
Operating Cycle
61.4795.18139.0392.4965.0125.04K48.4957.9662.2576.1938.6125.04K
Days of Payables Outstanding
42.3331.4145.9528.7525.2318.8425.5021.2021.5222.0021.5221.52
Cash Conversion Cycle
19.1363.7693.0763.7439.7825.02K22.9936.7640.7254.1817.4625.02K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A40.190.260.430.200.160.6940.19
Debt Equity Ratio
N/AN/AN/AN/AN/A87.660.618.280.680.402.3087.66
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.980.380.830.340.280.240.98
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.980.380.890.400.28N/A0.98
Interest Coverage Ratio
-4.22N/AN/AN/AN/AN/A-16.43N/AN/AN/A-8.62N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-0.01-1.41-1.59-1.79-1.10N/AN/A
Company Equity Multiplier
1.421.401.571.781.922.182.2719.163.302.453.301.92
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.07-0.29-0.23-0.36-0.32-0.44-0.47-0.54-0.23-0.11-0.14-0.32
Free Cash Flow / Operating Cash Flow Ratio
0.831.051.021.071.041.041.031.011.011.031.011.04
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-0.01-1.41-1.59-1.79-1.10N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-35.72N/A-4.28-8.16-38.57N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A